Jin-Hua Liang

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Jin-hua Liang, Jinhua Liang
Publication record
111 papers · 1,356 citations · H-index 21

PAPERS

Penpulimab in combination with lenalidomide and R-GemOx regimen (R2-GemOx-PD1i) in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm, phase 2 trial.
20260 citationsauthor #1
Dual-utility ctDNA in diffuse large B-cell lymphoma: integrated genotyping unveils minimal residual disease dynamics and subtype-specific clonal evolution.
20260 citationsauthor #1
Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trial
20260 citationsauthor #14
A Novel CD58 Mutation-Related Signature Predicts Prognosis Risk in Diffuse Large B-Cell Lymphoma Patients.
20252 citationsauthor #14
Prognostic Role of SOCS1 Mutations in Diffuse Large B-Cell Lymphoma.
20250 citationsauthor #14
PTPN2 Inhibition Disrupts Mitochondrial Renewal and Blocks TFRC‐Mediated Mitophagy to Exert Anti‐Tumor Activities in ALK‐Positive Anaplastic Large Cell Lymphoma
20252 citationsauthor #11
Clinical implications of ctDNA-based minimal residual disease detection in newly diagnosed peripheral T-cell lymphoma: a single-center cohort study
20252 citationsauthor #1
SH3GL1‐activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B‐cell lymphoma
20256 citationsauthor #15
BTG1 Mutation Correlates with Inferior Prognosis in Diffuse Large B-Cell Lymphoma.
20250 citationsauthor #13
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma
202412 citationsauthor #1
Analysis of CCND3 mutations in diffuse large B-cell lymphoma
20246 citationsauthor #12
PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma.
202410 citationsauthor #1
Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms
202410 citationsauthor #14
Revealing the heterogeneity of treatment resistance in less‐defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy
20246 citationsauthor #13
Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century
20242 citationsauthor #6
The prognostic significance of MYC/BCL2 double expression in DLBCL in the genetic classification era
20242 citationsauthor #13
CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.
202416 citationsauthor #14
25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas
20230 citationsauthor #4
Dynamic changes in circulating EBV-DNA load during treatment have prognostic values in EBV^+ DLBCL-NOS: a Chinese cohort study
20232 citationsauthor #11
Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma
20235 citationsauthor #9
MYC‐induced cytidine metabolism regulates survival and drug resistance via cGas‐STING pathway in mantle cell lymphoma
20239 citationsauthor #1
Low T3 syndrome as a predictor of poor prognosis in peripheral T-cell lymphomas
20230 citationsauthor #7
Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial
20233 citationsauthor #8
Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia
20239 citationsauthor #6
NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia
20230 citationsauthor #6
P1133: CHIDAMIDE PLUS PREDNISONE, CYCLOPHOSPHAMIDE, AND THALIDOMIDE (CPCT) FOR RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA: A MULTICENTER PHASE II TRIAL
20230 citationsauthor #1
Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma
20233 citationsauthor #6
Prognostic significance of absolute monocyte count and lymphocyte to monocyte ratio in mucosa-associated lymphoid tissue (MALT) lymphoma
20233 citationsauthor #4
[Clonotypic analysis of immunoglobulin heavy chain sequences among 44 patients with Waldenström macroglobulinemia].
20230 citationsauthor #7
Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia
202212 citationsauthor #8
Chidamide Plus Prednisone, Cyclophosphamide, and Thalidomide (CPCT) for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Multicenter Phase II Trial
20220 citationsauthor #2
Population age structure and dynamics of Pinus koraiensis in a broadleaved Korean pine forest in Changbai Mountain, China
20228 citationsauthor #3
Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia
20221 citationsauthor #1
EBV-Mir-BART5-5p targets p53 independent pathway in cytoplasm: Potential role in EBV lymphomagenesis
20225 citationsauthor #9
Preliminary Results of Penpulimab Combined with RMA (rituximab, methotrexate, and cytarabine) for Newly Diagnosed Primary Central Nervous System Lymphoma
20220 citationsauthor #3
Prognostic nutritional index, a novel biomarker which predicts worse prognosis in diffuse large B cell lymphoma.
202112 citationsauthor #5
Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma.
20217 citationsauthor #10
Low serum cholesterol levels predict inferior prognosis and improve prognostic index scoring for peripheral T-cell lymphoma, unspecified.
20215 citationsauthor #5
Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma
20214 citationsauthor #4
Circulating low CD4+/CD8+ ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients
20218 citationsauthor #4
Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases
202123 citationsauthor #5
Autologous Stem Cell Transplantation after Conditioning with Chidamide Plus Carmustine, Etoposide, Cytarabine, and Cyclophosphamide (Chi-BEAC) for Treatment of High-Risk and Relapsed/Refractory Aggressive Lymphoma: Multi-Center, Single-Arm, Open-Label Phase II Clinical Trial
20211 citationsauthor #10
25-Hydroxy vitamin D deficiency predicts inferior prognosis in Hodgkin lymphoma.
20218 citationsauthor #10
Prognostic significance of serum immunoglobulin paraprotein in mucosa‐associated lymphoid tissue (MALT) lymphoma
20214 citationsauthor #3
High plasma D-dimer level is a poor prognostic factor for patients with waldenström macroglobulinemia
20201 citationsauthor #5
Chidamide, a histone deacetylase inhibitor, inhibits autophagy and exhibits therapeutic implication in chronic lymphocytic leukemia
202010 citationsauthor #3
[Clinical Characteristics and Prognosis of 56 Lymphoma Patients with Mediastinal Masses].
20200 citationsauthor #5
Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma
202011 citationsauthor #9
High viral loads of circulating Epstein-Barr virus DNA copy number in peripheral blood is associated with inferior prognosis in patients with mantle cell lymphoma
20206 citationsauthor #2
25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphoma
202018 citationsauthor #2
The prognostic roles of hypogammaglobulinemia and hypocomplementemia in newly diagnosed diffuse large B-cell lymphoma
20209 citationsauthor #6
Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial
202024 citationsauthor #1
Interim response in diffuse large B cell lymphoma on CT: what is the optimal size reduction (ΔSPD) for predicting outcome?
20200 citationsauthor #3
The prognostic value of 25-hydroxy vitamin D deficiency and its interaction with c-Myc expression in diffuse large B cell lymphoma
20208 citationsauthor #2
A new SH2D1A mutation in a female adult XLP disease with hemophagocytic lymphohistiocytosis and NK-cell leukemia
20196 citationsauthor #1
Clinical characteristics and outcomes for HIV-associated Diffuse Large B-cell Lymphoma in China: A retrospective single-center study
201913 citationsauthor #10
The prognostic role of 18F-FDG PET/CT baseline quantitative metabolic parameters in peripheral T-cell lymphoma
20195 citationsauthor #3
Tumor Abnormal Protein Level Predicts Disease Response and Progression of Diffuse Large B-Cell Lymphoma in the Rituximab Era.
20191 citationsauthor #6
Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis
20195 citationsauthor #3
Pathogenic Gene Mutations or Variants Identified by Targeted Gene Sequencing in Adults With Hemophagocytic Lymphohistiocytosis
201965 citationsauthor #11
[Clinical Analysis of 37 Patients with Primary Tonsil Diffuse Large B Cell Lymphoma].
20190 citationsauthor #4
Diabetes mellitus predicts inferior survival in diffuse large B-cell lymphoma: a propensity score-matched analysis
201913 citationsauthor #2
Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with chronic lymphocytic leukemia
20192 citationsauthor #6
PRIMARY THYMIC MUCOSA‐ASSOCIATED LYMPHOID TISSUE LYMPHOMA: 7 CLINICAL CASES REPORT AND A REVIEW OF THE LITERATURE
20194 citationsauthor #5
SF3B1 mutation predicts unfavorable treatment-free survival in Chinese chronic lymphocytic leukemia patients.
201912 citationsauthor #7
Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular Lymphoma
201930 citationsauthor #1
Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p/PML axis
201952 citationsauthor #7
Low absolute NK cell counts in peripheral blood are associated with inferior survival in patients with mantle cell lymphoma
201910 citationsauthor #3
EBV-miR-BHRF1-1 Targets p53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia
201912 citationsauthor #11
Prognostic significance of peripheral blood absolute monocyte count and lymphocyte to monocyte ratio in anaplastic large cell lymphoma
20188 citationsauthor #4
NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia
201817 citationsauthor #4
Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma
201812 citationsauthor #4
The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH
201819 citationsauthor #1
Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases
201824 citationsauthor #10
CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma
201811 citationsauthor #6
Low serum cholesterol levels predict inferior prognosis and improve NCCN‐IPI scoring in diffuse large B cell lymphoma
201845 citationsauthor #2
DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma
201826 citationsauthor #2
淋巴细胞/单核细胞比值在血管免疫母细胞性T细胞淋巴瘤患者中的预后价值
20182 citationsauthor #5
Ocular adnexal mucosa-associated lymphoid tissue lymphoma: a single center experience of 32 patients from China.
20182 citationsauthor #4
Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy
201813 citationsauthor #6
The percentage of cells with 17p deletion and the size of 17p deletion subclones show prognostic significance in chronic lymphocytic leukemia
20189 citationsauthor #5
Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia
201840 citationsauthor #4
Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia
201840 citationsauthor #7
Expression of autophagy related genes in chronic lymphocytic leukemia is associated with disease course.
201820 citationsauthor #5
Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial.
201846 citationsauthor #5
Prognostic significance of serum immunoglobulin paraprotein in patients with diffuse large B cell lymphoma
201811 citationsauthor #4
The prognostic role of HBV infection in chronic lymphocytic leukemia
20185 citationsauthor #1
Low Serum Cholesterol Levels Predict Inferior Prognosis in Diffuse Large B Cell Lymphoma
20170 citationsauthor #3
Prognostic Value of Baseline and Interim Total Metabolic Tumour Volume and Total Lesion Glycolysis Measured on 18f-FDG PET/CT in Patients with Follicular Lymphoma
20173 citationsauthor #1
Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma
201741 citationsauthor #2
Definition of disease‐progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables
20174 citationsauthor #3
Serum carbohydrate antigen 125 concentration as a superior predictor for serosal effusion at diagnosis and a prognostic factor in diffuse large B-cell lymphoma
201613 citationsauthor #4
Low natural killer (NK) cell counts in peripheral blood adversely affect clinical outcome of patients with follicular lymphoma
201625 citationsauthor #6
Elevated absolute monocyte count predicts unfavorable outcomes in patients with angioimmunoblastic T-cell lymphoma.
20166 citationsauthor #2
Thymic hyperplasia after chemotherapy in adults with mature B cell lymphoma and its influence on thymic output and CD4+ T cells repopulation
201625 citationsauthor #4
The distinct clinical features and prognosis of the CD10+MUM1+ and CD10−Bcl6−MUM1− diffuse large B-cell lymphoma
201640 citationsauthor #5
Prognostic value of whole-body SUVmax of nodal and extra-nodal lesions detected by 18F-FDG PET/CT in extra-nodal NK/T-cell lymphoma
201614 citationsauthor #1
Low absolute CD4+ T cell counts in peripheral blood are associated with inferior survival in follicular lymphoma
201612 citationsauthor #2
Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming
201639 citationsauthor #12
Efficacy of Pegaspargase, Etoposide, Methotrexate and Dexamethasone (PEMD) in Newly-Diagnosed Advanced-Stage Extra-Nodal Natural Killer (NK)/T-Cell Lymphoma
20160 citationsauthor #2

TIMELINE

1998 26 citations

2014 0 citations

2015 216 citations

2016 196 citations

2017 48 citations

2018 350 citations

2019 230 citations

2020 87 citations

2021 72 citations

2022 26 citations

2023 34 citations

2024 64 citations

2025 12 citations

2026 0 citations

Jin-Hua Liang

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT